These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34615383)

  • 1.
    Barreto TL; Lopes LB; Melo AS; Ishida K
    Future Microbiol; 2021 Oct; 16():1153-1160. PubMed ID: 34615383
    [No Abstract]   [Full Text] [Related]  

  • 2. Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis.
    Spadari CC; de Bastiani FWMDS; Lopes LB; Ishida K
    Int J Nanomedicine; 2019; 14():5187-5199. PubMed ID: 31371955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miltefosine as an alternative strategy in the treatment of the emerging fungus Candida auris.
    Barreto TL; Rossato L; de Freitas ALD; Meis JF; Lopes LB; Colombo AL; Ishida K
    Int J Antimicrob Agents; 2020 Aug; 56(2):106049. PubMed ID: 32544569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
    Zhang M; Su X; Sun WK; Chen F; Xu XY; Shi Y
    Mycopathologia; 2014 Feb; 177(1-2):11-8. PubMed ID: 24306184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro interaction between glabridin and voriconazole against Aspergillus fumigatus isolates.
    Nabili M; Aslani N; Shokohi T; Hedayati MT; Hassanmoghadam F; Moazeni M
    Rev Iberoam Micol; 2021; 38(3):145-147. PubMed ID: 33965316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine.
    Dos Reis TF; Horta MAC; Colabardini AC; Fernandes CM; Silva LP; Bastos RW; Fonseca MVL; Wang F; Martins C; Rodrigues ML; Silva Pereira C; Del Poeta M; Wong KH; Goldman GH
    mBio; 2021 Aug; 12(4):e0145821. PubMed ID: 34372704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antifungal susceptibility of clinical and environmental isolates of Aspergillus fumigatus and Aspergillus flavus in Brazil.
    Bedin Denardi L; Hoch Dalla-Lana B; Pantella Kunz de Jesus F; Bittencourt Severo C; Morais Santurio J; Zanette RA; Hartz Alves S
    Braz J Infect Dis; 2018; 22(1):30-36. PubMed ID: 29172033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Givinostat exhibits in vitro synergy with posaconazole against Aspergillus spp.
    Sun Y; Gao L; He C; Wu Q; Li M; Zeng T
    Med Mycol; 2017 Oct; 55(7):798-802. PubMed ID: 27915302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro combination of voriconazole and miltefosine against clinically relevant molds.
    Imbert S; Palous M; Meyer I; Dannaoui E; Mazier D; Datry A; Fekkar A
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6996-8. PubMed ID: 25199776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oleylphosphocholine (OlPC) in vitro and in a mouse model of invasive aspergillosis.
    Paulussen C; Boulet G; Bosschaerts T; Cos P; Fortin A; Maes L
    Mycoses; 2015 Mar; 58(3):127-32. PubMed ID: 25590577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
    Meletiadis J; Al-Saigh R; Velegraki A; Walsh TJ; Roilides E; Zerva L
    Antimicrob Agents Chemother; 2012 Jan; 56(1):403-10. PubMed ID: 22064546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vitro and in vivo study on the synergistic effect and mechanism of itraconazole or voriconazole alone and in combination with tetrandrine against Aspergillus fumigatus.
    Li SX; Song YJ; Zhang LL; Shi JP; Ma ZL; Guo H; Dong HY; Li YM; Zhang H
    J Med Microbiol; 2015 Sep; 64(9):1008-1020. PubMed ID: 26296880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole.
    Serrano MC; Morilla D; Valverde A; Chávez M; Espinel-Ingroff A; Claro R; Ramírez M; Mazuelos EM
    J Clin Microbiol; 2003 Nov; 41(11):5270-2. PubMed ID: 14605181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis.
    Liu W; Sun Y; Chen W; Liu W; Wan Z; Bu D; Li R
    Antimicrob Agents Chemother; 2012 May; 56(5):2598-603. PubMed ID: 22314539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.
    Alcazar-Fuoli L; Buitrago M; Gomez-Lopez A; Mellado E
    Virulence; 2015; 6(4):376-84. PubMed ID: 26065322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of Multiple Resistance Mechanisms in Voriconazole-Resistant Aspergillus flavus Clinical Isolates from a Chest Hospital Surveillance in Delhi, India.
    Sharma C; Kumar R; Kumar N; Masih A; Gupta D; Chowdhary A
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of protein binding on the activity of voriconazole alone or combined with anidulafungin against Aspergillus spp. using a time-kill methodology.
    Cafini F; Sevillano D; Alou L; Gómez-Aguado F; Corcuera MT; González N; Guinea J; Prieto J
    Rev Esp Quimioter; 2012 Mar; 25(1):47-55. PubMed ID: 22488542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of
    Ukai Y; Kuroiwa M; Kurihara N; Naruse H; Homma T; Maki H; Naito A
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126960
    [No Abstract]   [Full Text] [Related]  

  • 19. Powerful and Real-Time Quantification of Antifungal Efficacy against Triazole-Resistant and -Susceptible Aspergillus fumigatus Infections in Galleria mellonella by Longitudinal Bioluminescence Imaging.
    Vanhoffelen E; Michiels L; Brock M; Lagrou K; Reséndiz-Sharpe A; Vande Velde G
    Microbiol Spectr; 2023 Aug; 11(4):e0082523. PubMed ID: 37466453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles.
    Kammoun AK; Khedr A; Hegazy MA; Almalki AJ; Hosny KM; Abualsunun WA; Murshid SSA; Bakhaidar RB
    Drug Deliv; 2021 Dec; 28(1):2229-2240. PubMed ID: 34668818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.